Combination treatments for myelofibrosis in JAK inhibitor-naive patients: evidence, rationale, and clinical direction.
Saved in:
| Title: | Combination treatments for myelofibrosis in JAK inhibitor-naive patients: evidence, rationale, and clinical direction. |
|---|---|
| Authors: | Gagnon LL; Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, UK.; Department of Haematology CHU de Québec-Université Laval, Quebec, QC, Canada., Harrison CN; Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, UK. |
| Source: | Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2026 Apr; Vol. 27 (5), pp. 439-450. Date of Electronic Publication: 2026 Apr 02. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Informa Healthcare Country of Publication: England NLM ID: 100897346 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7666 (Electronic) Linking ISSN: 14656566 NLM ISO Abbreviation: Expert Opin Pharmacother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
